Biomarkers and Precision Oncology Forum – BPOF shared on LinkedIn:
“The oncology field moves monthly. Can your practice keep up?
Precision oncology is evolving faster than almost any field in medicine — new drugs, new biomarkers, new targets. Falling behind isn’t an option when your patients are counting on the latest evidence.
That’s exactly why we built BPOF 2026 — Moving the Needle in Precision Oncology.
Date: 30 July 2026 (Thursday), 09:00–16:15 SGT
Location: Academia, Singapore
Why this forum earns your day away from clinic:
Four live Molecular Tumour Boards — Precision Oncology and Hematology, Breast, Gynecological and Genitourinary Cancer. Real cases, real debate, immediately applicable to Monday’s clinic.
4 CME (SMC) plus 4 CPE (SNB) accredited — recognised, rigorous, and worth your time.
Regional faculty, one room — leaders from Singapore, India, Taiwan, the Philippines and the UAE sharing what’s actually changing practice, from ADC sequencing to HRD testing to MRD integration.
The conversations you can’t stream — tumour boards, corridor debates, and the peer network that a YouTube lecture will never give you.
Whether you’re a trainee closing knowledge gaps, a consultant staying current, or a leader shaping the field — there’s a seat here with your name on it.
Seats are limited. Register now.”
Other posts about BPOF 2026 on OncoDaily.
